• Info
  • Insider Ownership

Insider Trading & Ownership of Heath Lukatch

Location
San Carlos, CA
Summary
The estimated net worth of Heath Lukatch is at least $572,337 dollars as of 16 Jun 2025. Heath Lukatch is the Director of Vaxcyte, Inc. and owns shares of Vaxcyte, Inc. (PCVX) stock worth about $499.3K. Heath Lukatch is the Director of Inogen Inc and owns shares of Inogen Inc (INGN) stock worth about $73.1K.
Signature
Heath Lukatch, by /s/ Peter N. Efremenko, Attorney-In-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Heath Lukatch and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • Heath Lukatch has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $572,337.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Vaxcyte, Inc. ($499,264).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Heath Lukatch

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PCVX Vaxcyte, Inc. Director $499,264 12 Jun 2025
INGN Inogen Inc Director $73,073 10 May 2021
FLXN Flexion Therapeutics Inc Director 19 Nov 2021
STSA Satsuma Pharmaceuticals, Inc. Director 08 Jun 2023

Insider Transactions Reported by Heath Lukatch:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.